142 related articles for article (PubMed ID: 32115698)
41. A novel mutation of the tyrosinase gene causing oculocutaneous albinism type 1 (OCA1).
Nakamura E; Miyamura Y; Matsunaga J; Kano Y; Dakeishi-Hara M; Tanita M; Kono M; Tomita Y
J Dermatol Sci; 2002 Feb; 28(2):102-5. PubMed ID: 11858948
[TBL] [Abstract][Full Text] [Related]
42. Genetic analysis and prenatal diagnosis of 20 Chinese families with oculocutaneous albinism.
Xu C; Xiang Y; Li H; Xu Y; Mao Y; Zhou L; Xu X; Tang S
J Clin Lab Anal; 2021 Feb; 35(2):e23647. PubMed ID: 33124154
[TBL] [Abstract][Full Text] [Related]
43. Mutation Analysis of 63 Northwest Chinese Probands with Oculocutaneous Albinism.
Chuan Z; Yan Y; Hao S; Zhang Q; Zhou B; Feng X; Wang X; Liu F; Zheng L; Cao Z; Ma X
Curr Eye Res; 2021 Jan; 46(1):140-143. PubMed ID: 32552135
[TBL] [Abstract][Full Text] [Related]
44. Functional validation of the albinism-associated tyrosinase T373K SNP by CRISPR/Cas9-mediated homology-directed repair (HDR) in rabbits.
Song Y; Zhang Y; Chen M; Deng J; Sui T; Lai L; Li Z
EBioMedicine; 2018 Oct; 36():517-525. PubMed ID: 30274819
[TBL] [Abstract][Full Text] [Related]
45. Ophthalmo-genetic analysis of Pakistani patients with nonsyndromic oculocutaneous albinism through whole exome sequencing.
Gul H; Ali MZ; Khan E; Zubair M; Badar M; Khan S; Shah AH; Khan MA
J Pak Med Assoc; 2017 May; 67(5):790-792. PubMed ID: 28507374
[TBL] [Abstract][Full Text] [Related]
46. Identification of Five Novel Variants in Chinese Oculocutaneous Albinism by Targeted Next-Generation Sequencing.
Qiu B; Ma T; Peng C; Zheng X; Yang J
Genet Test Mol Biomarkers; 2018 Apr; 22(4):252-258. PubMed ID: 29437493
[TBL] [Abstract][Full Text] [Related]
47. Rapid genetic analysis of oculocutaneous albinism (OCA1) using denaturing high performance liquid chromatography (DHPLC) system.
Lin SY; Chien SC; Su YN; Lee CN; Chen CP
Prenat Diagn; 2006 May; 26(5):466-70. PubMed ID: 16570240
[TBL] [Abstract][Full Text] [Related]
48. Haplotype-based analysis resolves missing heritability in oculocutaneous albinism type 1B.
Loftus SK; Gillis MF; Lundh L; Baxter LL; Wedel JC; Watkins-Chow DE; Donovan FX; ; Sergeev YV; Oetting WS; Pavan WJ; Adams DR
Am J Hum Genet; 2023 Jul; 110(7):1123-1137. PubMed ID: 37327787
[TBL] [Abstract][Full Text] [Related]
49. Insertion/deletion mutations of type I oculocutaneous albinism in chinese patients from Taiwan.
Tsai CH; Tsai FJ; Wu JY; Lin SP; Chang JG; Yang CF; Lee CC
Hum Mutat; 1999 Dec; 14(6):542. PubMed ID: 10571953
[TBL] [Abstract][Full Text] [Related]
50. DNA-based prenatal diagnosis of a Korean family with tyrosinase-related oculocutaneous albinism (OCA1).
Lee ST; Park SK; Lee H; Lee JS; Park YW
Jpn J Hum Genet; 1997 Dec; 42(4):499-505. PubMed ID: 9560949
[TBL] [Abstract][Full Text] [Related]
51. Nitisinone improves eye and skin pigmentation defects in a mouse model of oculocutaneous albinism.
Onojafe IF; Adams DR; Simeonov DR; Zhang J; Chan CC; Bernardini IM; Sergeev YV; Dolinska MB; Alur RP; Brilliant MH; Gahl WA; Brooks BP
J Clin Invest; 2011 Oct; 121(10):3914-23. PubMed ID: 21968110
[TBL] [Abstract][Full Text] [Related]
52. A comprehensive genetic study of autosomal recessive ocular albinism in Caucasian patients.
Hutton SM; Spritz RA
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):868-72. PubMed ID: 18326704
[TBL] [Abstract][Full Text] [Related]
53. [Genetic testing and prenatal diagnosis for thirteen Chinese pedigrees affected with oculocutaneous albinism].
Yang Y; Mao B; Wang Q; Lie S; Zhang R; Zhao X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Feb; 39(2):143-147. PubMed ID: 35076908
[TBL] [Abstract][Full Text] [Related]
54. Oculocutaneous albinism type 1B associated with a functionally significant tyrosinase gene polymorphism detected with Whole Exome Sequencing.
Mendez R; Iqbal S; Vishnopolska S; Martinez C; Dibner G; Aliano R; Zaiat J; Biagioli G; Fernandez C; Turjanski A; Campbell AJ; Mercado G; Marti MA
Ophthalmic Genet; 2021 Jun; 42(3):291-295. PubMed ID: 33599182
[No Abstract] [Full Text] [Related]
55. Mutation analysis of the tyrosinase gene in oculocutaneous albinism.
Camand O; Marchant D; Boutboul S; Péquignot M; Odent S; Dollfus H; Sutherland J; Levin A; Menasche M; Marsac C; Dufier JL; Heon E; Abitbol M
Hum Mutat; 2001 Apr; 17(4):352. PubMed ID: 11295837
[TBL] [Abstract][Full Text] [Related]
56. Germline variants in oculocutaneous albinism genes and predisposition to familial cutaneous melanoma.
Nathan V; Johansson PA; Palmer JM; Howlie M; Hamilton HR; Wadt K; Jönsson G; Brooks KM; Pritchard AL; Hayward NK
Pigment Cell Melanoma Res; 2019 Nov; 32(6):854-863. PubMed ID: 31233279
[TBL] [Abstract][Full Text] [Related]
57. Five novel mutations in tyrosinase gene of Japanese and Indian patients with oculocutaneous albinism type I (OCA1).
Miyamura Y; Verma IC; Saxena R; Hoshi M; Murase A; Nakamura E; Kono M; Suzuki T; Yasue S; Shibata S; Sakakibara A; Tomita Y
J Invest Dermatol; 2005 Aug; 125(2):397-8. PubMed ID: 16098056
[No Abstract] [Full Text] [Related]
58. [Early prenatal genetic diagnosis of oculocutaneous albinism type I in seven families].
Wu Q; Shi HR; Liu N; Lu N; Jiang M; Zhao ZH; Kong XD
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Aug; 29(4):377-81. PubMed ID: 22875490
[TBL] [Abstract][Full Text] [Related]
59. Novel mutations of the tyrosinase (TYR) gene in type I oculocutaneous albinism (OCA1).
Spritz RA; Oh J; Fukai K; Holmes SA; Ho L; Chitayat D; France TD; Musarella MA; Orlow SJ; Schnur RE; Weleber RG; Levin AV
Hum Mutat; 1997; 10(2):171-4. PubMed ID: 9259202
[No Abstract] [Full Text] [Related]
60. Tyrosinase and ocular diseases: some novel thoughts on the molecular basis of oculocutaneous albinism type 1.
Ray K; Chaki M; Sengupta M
Prog Retin Eye Res; 2007 Jul; 26(4):323-58. PubMed ID: 17355913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
